Impact of Blocking the Glossopharyngeal Nerve on Gastroesophageal Reflux Disease
NCT06304870 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2024-03-15
Summary
The goal of this clinical trial is to explore Clinical Effect of Glossopharyngeal Nerve Block on Pharyngeal Dysphagia Induced by Gastroesophageal Reflux Disease. The main question it aims to answer is:
• Can Glossopharyngeal Nerve Block improve dysphagia caused by gastroesophageal reflux symptoms on the basis of rehabilitation training? Participants will be randomly allocated into the control group or the experimental group, all under rehabilitation treatment, the experimental group will be given Glossopharyngeal Nerve Block once a day additionally. The study lasts 20 days for each participant. Researchers will compare the Rosenbek penetration-aspiration scale, Gastroesophageal Reflux Disease Questionnaire, Pressure pain threshold, to see if the Glossopharyngeal Nerve Block can help improve the symptom.
Conditions
Interventions
- BEHAVIORAL
-
Rehabilitation therapy
Rehabilitation therapy includes Diet management: Avoiding consumption of irritant foods and beverages, such as spicy foods, caffeine, alcohol, and acidic foods. Controlling portion sizes and meal timing, and adopting smaller, more frequent meals. Lifestyle adjustments: Avoiding lying down or bending immediately after meals, maintaining a sitting or upright position for at least 2 hours. Adjusting sleeping positions by elevating the head of the bed to reduce nighttime acid reflux. Avoiding excessive exertion and managing stress levels. Rehabilitation training: Strengthening the control of esophageal and gastric muscles through rehabilitation exercises to improve the function of the gastroesophageal sphincter and prevent gastric fluid reflux.
- DRUG
-
Lidocaine
The patient lies supine without a pillow, turns the head to the contralateral side of the block, and at the midpoint of the line connecting the angle of the mandible with the mastoid process (the styloid process), the skin is disinfected, and a 22-gauge, 3.8 cm puncture needle is loaded onto a 5 mL syringe. The puncture needle is inserted perpendicularly to the skin surface at the styloid process, and advanced through the skin and subcutaneous tissue until it contacts the bone of the styloid process. The puncture needle is then retracted and advanced anteriorly beyond the styloid process by 0.5-1.0 cm. When no blood or cerebrospinal fluid is aspirated, the blocking drug can be injected \[20 g/L lidocaine injection\].
- PROCEDURE
-
Injection
The patient lies supine without a pillow, turns the head to the contralateral side of the block, and at the midpoint of the line connecting the angle of the mandible with the mastoid process (the styloid process), the skin is disinfected, and a 22-gauge, 3.8 cm puncture needle is loaded onto a 5 mL syringe. The puncture needle is inserted perpendicularly to the skin surface at the styloid process, and advanced through the skin and subcutaneous tissue until it contacts the bone of the styloid process.
Sponsors & Collaborators
-
Muhammad
lead OTHER
Principal Investigators
-
Nieto Luis, Master · Site Coordinator of United Medical Group
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-03-31
- Primary Completion
- 2024-06-30
- Completion
- 2024-06-30
More Related Trials
-
Mirabegron in Achalasia: A Clinical and Manometric Proof of Concept Pilot Study
NCT03411252 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Effect of Manual Diaphragmatic Activation on Diaphragm Function in Patients With Gastroesophageal Reflux Disease
NCT06268548 ·Status: RECRUITING ·Phase: NA
-
Topical Pharyngeal Anesthesia in Sedated Esophagogastroduodenoscopy
NCT03070379 ·Status: UNKNOWN ·Phase: NA
-
Treatment Of Gastroesophageal Reflux Disease By Endoscopic Fundoplication, A Placebo-Controlled Study
NCT00235677 ·Status: COMPLETED ·Phase: PHASE3
-
Radiofrequency Ablation vs Sham Procedure for Symptomatic Cervical Inlet Patch
NCT03471052 ·Status: UNKNOWN ·Phase: NA
-
A Blinded Randomized Clinical Study of RefluxStop™ Compared With Nissen Fundoplication in the Treatment of GERD
NCT07004400 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effects of AFQ056 and Baclofen on Meal-Induced Gastroesophageal Reflux
NCT00414856 ·Status: COMPLETED ·Phase: PHASE1
-
Design and Implementation of a Nutritional Intervention in Patients With Oropharyngeal Dysphagia
NCT02959450 ·Status: COMPLETED ·Phase: NA
-
Performance and Safety of Afluxin® in Patients With Gastroesophageal Reflux Disease
NCT06984484 ·Status: RECRUITING ·Phase: NA
-
Efficacy of Gut-Brain Neuromodulators in the Treatment of Gastroesophageal Reflux Disease
NCT06945237 ·Status: COMPLETED ·Phase: NA
-
Standardized Dysphagia Diet in Clinical Evaluation of Swallowing Function
NCT05634980 ·Status: UNKNOWN
-
Whether Proton Pump Inhibitors, Administered Prior to or After Surgery, Can Reduce the Incidence and/or Severity of Difficulty Swallowing Foods and/or Liquids,Following Anterior Cervical Surgery
NCT03488147 ·Status: WITHDRAWN ·Phase: PHASE2
-
ThickenUp® Gel Express for Patients with Dysphagia
NCT04741581 ·Status: COMPLETED ·Phase: NA
-
A Novel Endoloop Pre-test to Treat Gastroesophageal Reflux
NCT05192538 ·Status: UNKNOWN ·Phase: NA
-
Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non-Erosive Gastroesophageal Reflux Disease (NERD)
NCT06121830 ·Status: RECRUITING ·Phase: PHASE3
-
Effect of a Combination of Hyaluronic Acid, Chondroitin Sulphate and Magnesium Trisilicate on Subjects With GastroEsophageal Reflux Disease
NCT03883074 ·Status: COMPLETED ·Phase: NA
-
Efficacy & Safety of Submucosal Endoscopic Myotomy With Mucosal Flap (SEMF) in the Treatment of Patients With Achalasia
NCT01438398 ·Status: COMPLETED ·Phase: NA
-
Radiofrequency Energy Delivery for Gastroesophageal Reflux Disease
NCT03223116 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Two Therapies for Upper Esophageal Sphincter (UES) Dysphagia
NCT00059670 ·Status: COMPLETED ·Phase: NA
-
Comparison of Voice Therapy and Antireflex Therapy in LPR
NCT02530879 ·Status: WITHDRAWN ·Phase: PHASE4
-
Assessment on Effects of Tongjiang Granule in Treating Nonerosive Reflux Disease Overlapping Epigastric Pain Syndrome
NCT05312463 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Medical and Surgical Treatment of Esophageal Reflux
NCT00061724 ·Status: COMPLETED
-
A New System for GERD Diagnosis and Treatment
NCT03600974 ·Status: UNKNOWN
-
Phase 3 Study of TAK-438 10 mg in the Treatment of Non-Erosive Gastroesophageal Reflux Disease (NERD)
NCT02954848 ·Status: COMPLETED ·Phase: PHASE3
-
Understanding the Pathophysiology and Effects of Diaphragmatic Breathing in Upright Gastroesophageal Reflux
NCT02972047 ·Status: COMPLETED ·Phase: NA